Fieldview Capital Management’s Krystal Biotech KRYS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2M Sell
14,546
-1,796
-11% -$247K 0.3% 130
2025
Q1
$2.95M Buy
+16,342
New +$2.95M 0.42% 89